Access cutting-edge gastric cancer treatment through this clinical trial at a research site in Irvine. Study-provided care at no cost to qualified participants.
Access gastric cancer specialists in Irvine at no cost
This study follows strict safety protocols and ethical guidelines
All study-related gastric cancer treatment provided free
This study will assess the efficacy, safety, optimal dose and ADA and NAbs development of TRK-950 at two separate dose levels in combination with ramucirumab and paclitaxel (RAM+PTX) as compared with RAM + PTX treatment alone in participants with gastric or gastro-esophageal junction (GEJ) adenocarcinoma.
Sponsor: Toray Industries, Inc
Check if you qualify for this gastric cancer clinical trial in Irvine, CA
If you're searching for gastric cancer treatment options in Irvine, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Irvine research site is actively enrolling participants for this clinical trial. You'll receive care from experienced gastric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.